Inflammation and Atherosclerosis: Atherosclerotic Lesions in Takayasu Arteritis

• Published in: Annals of the New York Academy of Sciences Vol. 902; no. 1; pp. 65 - 76
• Main Authors: NUMANO, FUJIO, KISHI, YUKIO, TANAKA, AKIRA, OHKAWARA, MIHO, KAKUTA, TSUNEKAZU, KOBAYASHI, YASUSHI
• Format: Journal Article
• Language: English
• Published: Oxford, UK Blackwell Publishing Ltd 01-05-2000
• Subjects: Arteries - pathology; Arteriosclerosis - pathology; Asia - epidemiology; Female; Humans; Inflammation - physiopathology; Latin America - epidemiology; Male; Prevalence; Takayasu Arteritis - epidemiology; Takayasu Arteritis - pathology; Takayasu Arteritis - physiopathology; Asia; Latin America
• ISSN: 0077-8923; 1749-6632
• DOI: 10.1111/j.1749-6632.2000.tb06301.x

: Takayasu arteritis is a chronic vasculitis, mainly involving the aorta and its main branches as well as the coronary and pulmonary arteries, causing stenosis and/or obstruction due to thrombus formation or dilatation due to aneurysmal formation and/or rupture of the involved arteries. These characteristic anomalies resulted from ischemia of retinal arteries due to the obstruction of cervical vessels. In Western countries this disease is also known as “pulseless disease,” because the pulse is frequently absent due to the obstruction of subclavian or brachial arteries. The pathogenesis of this morbid condition is still unknown. Epidemiologically, it is found mostly in female patients and is more prevalent in Asian and Latin American countries. Affected areas consist of a mixture of both active, productive inflammatory lesions, and old fibrous lesions. Autoimmune processes stimulated by viral infection and other unknown causative factors may play an important role under these pathophysiological conditions because HLA analysis revealed a statistically significant high frequency of haplotype A24‐B52‐DR2 in these patients in Japan. Documentation of atherosclerotic complications in young female patients with Takayasu arteritis who are generally free from traditional atherosclerosis risk factors may be clinical evidence that inflammation is indeed an important risk factor in atherogenesis.